Open AccessThe Toll–Like Receptor 2/6 Agonist, FSL–1 Lipopeptide, Therapeutically Mitigates Acute Radiation Syndrome
Author(s) -
Cathryn J. Kurkjian,
Hao Guo,
Nathan D. Montgomery,
Ning Cheng,
Hong Yan,
Joseph R. Merrill,
Gregory D. Sempowski,
W. June Brickey,
Jenny P.-Y. Ting
Publication year - 2017
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/q7cn-n578
Subject(s) - agonist , lipopeptide , receptor , medicine , acute radiation syndrome , toll like receptor , pharmacology , biology , innate immune system , bacteria , microbiology and biotechnology , stem cell , haematopoiesis , genetics